Northfield Laboratories (NASDAQOTH:NFLDQ.DL)

CAPS Rating No stars 
NFLDQ.DL VS S&P 500 (SPY)

This ticker is not currently Ratable.

Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPS

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 
Quote
Commentary
Scorecard
Historical Prices
Chart
Stats
Ratios
Earnings/Growth Rates
Statements
SEC Filings

NFLDQ.DL Summary

  • Sector:
  • Industry:
  • Tags:

Top NFLDQ.DL Bull/Bear Pitches

Godzilla110 (60.86)
Submitted January 17, 2007

Based on their burn rate, they should be out of cash and equivalents in about 2 years. I believe this is sufficient time for the company to improve the product enough to receive FDA approval. I'm taking this position based on the presidents letter to… More

Reply | Reply | Report this Post

NetscribeBiotech (92.45)
Submitted January 03, 2007

Northfield Laboratories is a development stage company engages in the research, development, testing, manufacture, marketing, and distribution of hemoglobin-based blood substitute products. Its primary investigational drug PolyHeme is a human… More

2 Comments | Reply | Report this Post

Fools bearish on NFLDQ.DL
are also bearish on:

Featured Broker Partners


Advertisement